(D-Arg0,Hyp3,D-Phe7,Leu8)-Bradykinin is a modified bradykinin analog featuring D-arginine, hydroxyproline, and D-phenylalanine substitutions to enhance receptor binding and metabolic stability. The modifications help stabilize the peptide for use in receptor-binding studies. Researchers use this peptide to explore the role of bradykinin in vasodilation and pain pathways, particularly in inflammatory response models.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More